US 10370366
Pyridazinone compounds and methods for the treatment of cystic fibrosis
granted A61KA61K31/38A61K31/4245
Quick answer
US patent 10370366 (Pyridazinone compounds and methods for the treatment of cystic fibrosis) held by Flatley Discovery Lab, LLC expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Flatley Discovery Lab, LLC
- Grant date
- Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/38, A61K31/4245, A61K31/443, A61K31/47